Haisco Pharmaceutical's controlling shareholder pledges and extends shares

Haisco Pharmaceutical Group Co., Ltd. announced that its controlling shareholder, Wang Junmin, has pledged an additional 15.5 million shares, representing 3.88% of his total holdings and 1.38% of the company's total share capital. This new pledge began on September 9, 2025, and is set to expire on September 6, 2028, or upon completion of the pledge cancellation process, with Guojin Securities Co., Ltd. as the pledgee. The purpose of this pledge is for his own production and operation.

Furthermore, Wang Junmin extended the term of an existing pledge involving 9 million shares, which constitutes 2.25% of his holdings and 0.80% of the company's total share capital. Originally pledged from September 9, 2024, to September 9, 2025, the new extended maturity date is September 8, 2026, or until the pledge cancellation process is completed. China Merchants Securities Co., Ltd. is the pledgee for this extended arrangement, also for the purpose of his own production and operation.

Following these transactions, Wang Junmin's total pledged shares amount to 103.94 million shares, representing 26.01% of his holdings and 9.28% of the company's total share capital. The announcement confirms that the pledged shares are not subject to any major asset restructuring or performance compensation obligations.